Avidity Biosciences Inc
RNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$233.32M
Close$
$-10.48
173.9% downside
Current Fair Value
173.9% downsideOvervalued by 173.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $233.32 Million |
|---|---|
| Enterprise Value | $171.40 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.48 |
| Beta | 0.37 |
| Outstanding Shares | 17,106,000 |
Return
| Return on Equity | -208.95% |
|---|---|
| Return on Assets | -159.84% |
| Return on Invested Capital | -181.30% |
Valuation & Multiples
| P/E Ratio | -3.54 |
|---|---|
| PEG | 4.06 |
| Price to Sales | 7.1 |
| Price to Book Ratio | 1.18 |
| Enterprise Value to Revenue | 4.76 |
| Enterprise Value to EBIT | -0.38 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-1.16
Average shareholder expectationRevenue Estimate
$666,667
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.87
Average shareholder expectationRevenue Estimate
$15.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 13.0927▼ 419.48% |
|---|---|
| Total Calls | 65,800▼ 0.30% |
| Total Puts | 861,500▼ 24.49% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 84.61%▼ 2.23% |
|---|---|
| Total Invested | $194.80M▼ 1.97% |
| Investors Holding | 159▼ 9.00% |
ESG Score
No data